Obesity medication liraglutide is safe and effective in children aged 6 to <12 years

Liraglutide treatment significantly lowers BMI in obese children aged 6 to <12, but gastrointestinal side effects prompt the need for additional studies.

Antibiotic overuse linked to poor record-keeping in healthcare settings

A lack of detailed record-keeping in clinics and emergency departments may be getting in the way of reducing the inappropriate use of antibiotics, a pair

May 17, 2024

Drug breakthrough provides new hope for cancer patients with cachexia

Researchers discovered a drug that safely and effectively helped cancer patients when they suffered from cachexia (ku-KEK-see-uh), a common condition related to cancer that involves

September 20, 2024

Rentschler names Benedikt von Braunmuehl as CEO; Catalent grabs David McErlane from Lonza as biologics lead

Benedikt von Braunmuehl has been revealed as Rentschler Biopharma’s new CEO. Meanwhile, Catalent also announced that David McErlane is the CDMO’s new group president of

September 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.